Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Prostatic Neoplasms 10Lung Neoplasms 10Breast Neoplasms 8Pancreatic Neoplasms 5Multiple Myeloma 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Ovarian Neoplasms 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphatic System Neoplasm 4Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Inflammatory Breast Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Pancreatic Ductal Adenocarcinoma 1Obesity 1

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Induced Peripheral Neuropathy × Specimen Handling × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡